Abstract
Rights: UNKNOWN · https://www.elsevier.com/tdm/userlicense/1.0/ · Source: journal-auto-sync:external:CROSSREF_ISSN
Siribang-on Piboonniyom, Stefanie Timmermann, Philip Hinds, Karl Münger
Abstract
Rights: UNKNOWN · https://www.elsevier.com/tdm/userlicense/1.0/ · Source: journal-auto-sync:external:CROSSREF_ISSN
Authors
Institutions
No ROR-resolved institution is linked to this work yet.
Provenance
crossref
Confidence 100%
pubmed
Confidence 98%
unpaywall
Confidence 95%
datacite
Confidence 0%
No local reference links have been materialized yet.
No local citing links have been materialized yet.
Head and neck cancer
10.1056/nejm199301213280306 · 1993
Estimates of the worldwide frequency of sixteen major cancers in 1980
10.1002/ijc.2910410205 · 1988
The high risk human papillomaviruses and oral cancer
10.1111/j.1601-0825.1997.tb00025.x · 1997
The INK4A/ARF locus and its two gene products
10.1016/s0959-437x(99)80004-5 · 1999
Association of p19(ARF) with Mdm2 inhibits ubiquitin ligase activity of Mdm2 for tumor suppressor p53
10.1093/emboj/18.1.22 · 1999
The retinoblastoma protein and cell cycle control
10.1016/0092-8674(95)90385-2 · 1995
Frequent inactivation of the retinoblastoma anti-oncogene is restricted to a subset of human tumors
10.1073/pnas.87.7.2775 · 1990
Expression and amplification of cyclin genes in human breast cancer
1993
Homozygous deletions of 9p21 in primary human bladder tumors detected by comparative multiplex polymerase chain reaction
1994
The human papillomavirus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product
10.1126/science.2537532 · 1989
Elevated activity of cyclin-dependent kinase 6 in human squamous cell carcinoma lines
1997
Tumorigenic keratinocyte lines requiring anchorage and fibroblast support cultures from human squamous cell carcinomas
1981
Expression of the peptide antibiotic human beta-defensin 1 in cultured gingival epithelial cells and gingival tissue
10.1128/iai.66.9.4222-4228.1998 · 1998
SV40 large tumor antigen forms a specific complex with the product of the retinoblastoma susceptibility gene
10.1016/0092-8674(88)90559-4 · 1988
D-type cyclin-dependent kinase activity in mammalian cells
10.1128/mcb.14.3.2066 · 1994
Identification of G(1) kinase activity for cdk6, a novel cyclin D partner
10.1128/mcb.14.3.2077 · 1994
Unresolved referenced work
1992
Analysis of the p16 gene (CDKN2) as a candidate for the chromosome 9p melanoma susceptibility locus
10.1038/ng0994-22 · 1994
Higher frequency of alterations in the p16/CDKN2 gene in squamous cell carcinoma cell lines than in primary tumors of the head and neck
1994
Genomic alterations of the p19ARF encoding exons in T-cell acute lymphoblastic leukemia
10.1182/blood.v91.3.1016 · 1998
Mutations of the INK4a locus in squamous cell carcinomas of human skin
10.1006/bbrc.1997.6217 · 1997
Methylation-specific PCR
10.1073/pnas.93.18.9821 · 1996
Re-expression of endogenous p16ink4a in oral squamous cell carcinoma lines by 5-aza-2′-deoxycytidine treatment induces a senescence-like state
10.1038/sj.onc.1202244 · 1998
Rapid nuclear translocation and increased activity of cyclin-dependent kinase 6 after T cell activation
10.4049/jimmunol.158.11.5146 · 1997
Active cdk6 complexes are predominantly nuclear and represent only a minority of the cdk6 in T cells
10.1038/sj.onc.1201570 · 1998
Structural basis for inhibition of the cyclin-dependent kinase Cdk6 by the tumour suppressor p16INK4a
10.1038/26155 · 1998
Association Of Cdkn2a/P16(Ink4a) with human head and neck keratinocyte replicative senescence — relationship of dysfunction to immortality and neoplasia
1996
Alternative reading frames of the INK4a tumor suppressor gene encode two unrelated proteins capable of inducing cell cycle arrest
10.1016/0092-8674(95)90214-7 · 1995
A novel p16INK4A transcript
1995
Mutations in human ARF exon 2 disrupt its nucleolar localization and impair its ability to block nuclear export of MDM2 and p53
10.1016/s1097-2765(00)80351-2 · 1999
Preferential loss of expression of p16(INK4a) rather than p19(ARF) in breast cancer
1996
Flavopiridol
10.1023/a:1006353008903 · 1999
No additional external references are available.